As reported previously, Susquehanna analyst Don Carson upgraded Chemours to Positive from Neutral citing significant upside he sees to management's modest EBITDA guidance due to greater momentum in TiO2 prices. He noted the prices are at the beginning of a multi-year cyclical rebound, while there will be continued structural cost reductions, faster adoption of Opteon refrigerant, and reduced litigation risk. Carson raised his price target to $40 from $26 on Chemours shares.
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here